A new PETMR technique that targets fibroblast activation protein (FAP) overexpressed in endometriosis is more effective at identifying lesions than conventional imaging. According to new research published in the August issue of The Journal of Nuclear Medicine, this approach was particularly effective in regions of the pelvis and abdomen that are typically difficult to image. By […]
Read MoreA newly developed radiotheranostic pair, 68Ga/177Lu-NYM096, can identify tumors and effectively deliver targeted radiotherapy to patients with metastatic clear cell renal cell carcinoma (ccRCC). Using a small molecule compound, the new approach helps to mitigate toxicity issues common with treatment, offering a safe and feasible strategy for those with end-stage disease. This research was published in the September issue of […]
Read MoreLow brain metabolism as measured from ¹⁸F-FDG PETCT is associated with higher mortality in patients with advanced non–small cell lung cancer (NSCLC), according to new research published in the July issue of The Journal of Nuclear Medicine. Incorporating brain ¹⁸F-FDG uptake alongside clinical, tumour, and biological data improved prediction of overall survival, providing physicians with valuable […]
Read More